Académique Documents
Professionnel Documents
Culture Documents
-=6
Indian Market
Indian equity markets were up 0.42% Nifty up by 24.65 pts and settle at 5922.50 Sensex up by 105.34 pts at 19565.91 Bank Nifty up by 76.80 pts at 12465.00
Global Market
European markets were down with FTSE up by 6.12 closed at 6283 ,CAC down by 2.22 closed at 3648 and DAX down by 25.72 closed at 7608. Dow future was down 18.00 closed at 13906.00
HEADLINES
SAIL Q3 net down 23% on higher finance cost, weak Re IT Sector exports seen up 12-14% in FY2014, says Nasscom Expect growth rate of 15-20%, NIMs sustainable at 5%: REC Poor manufacturing, consumption pull down Dec IIP -0.6%
WWW.EPICRESEARCH.CO
09752199966
MARKET ANALYSIS:
Key benchmark indices edged higher in choppy trade as bargain hunting emerged after a sustained slide in share prices over the past few trading sessions. BSE Sensex was up 106.14 points or 0.55% to 19,566.71 CNX Nifty was up 28.35 points or 0.45% to 5,924.20, Among the 30-share Sensex pack, 19 stocks rose while the rest of them fell. Oil exploration major ONGC jumped 4.02% on better than expected Q3 results. Jaiprakash Associates rose 0.14%, with the stock reversing initial losses. The company's net profit fell 64.2% to Rs 110.93 crore on 13.33% growth in total income to Rs 3516.83 crore in Q3 December 2012 over Q3 December 2011. Power Grid Corporation of India rose 0.4% after net profit jumped 39.52% to Rs 1129.06 crore on 35.47% growth in total income to Rs 3490.22 crore in Q3 December 2012 over Q3 December 2011. Sail gained 0.27%. The company's net profit fell 23.38% to Rs 484.30 crore on 1.99% decline in total income to Rs 10670.12 crore in Q3 December 2012 over Q3 December 2011 Pharma stocks rose on renewed buying. Wockhardt, Lupin and Glenmark Pharmaceuticals gained by 1.51% to 2.83%. Cipla and Ranbaxy Laboratories fell by 0.68% to 1.19%. Industrial production declined 0.6% in December 2012, data released by the Central Statistics Office (CSO), today, 12 February 2013, showed.
FII DII
12-Feb-13 12-Feb-13
2528.32 814.97
1924.16 1227.12
604.16 -412.15
5788
WWW.EPICRESEARCH.CO
09752199966
EXPERT OPINION
NIFTY
Nifty looks Bearish Strategy: Sell on rise Support: 5880 Resistance: 5970
BANK NIFTY
3.78 2.98
Bank Nifty looks Bearish Strategy: Sell on rise Support: 12400 Resistance: 12540 .0
2.88 2.63
1.96
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
B S S B
UPCOMING RESULTS
BPCL IOC TATA STEEL COAL INDIA
09752199966
WWW.EPICRESEARCH.CO
MARKET CALLS
CASH
SCRIPS STERLITE HDFC ACTION SELL SELL LEVEL 101.10 798.50 1ST TARGET 100.60 796.50 2ND TARGET 99.85 794.50 STOP LOSS 101.60 800.50
FUTURE
SCRIPS . AUROBINDO PHARMA INDUSIND BANK SELL 179.00 178.00 176.50 180.50 ACTION LEVEL 1
ST
TARGET
ND
TARGET
STOP LOSS
BUY
440.50
442.50
444.50
438.50
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.